HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $647,529 | -96.8% | 17,952 | -96.6% | 0.00% | -96.7% |
| Q1 2023 | $20,426,303 | +249.2% | 534,860 | +420.2% | 0.03% | +233.3% |
| Q4 2022 | $5,850,287 | +259.1% | 102,817 | +149.6% | 0.01% | +200.0% |
| Q3 2022 | $1,629,000 | -50.9% | 41,197 | -49.5% | 0.00% | -40.0% |
| Q3 2021 | $3,321,000 | -88.8% | 81,637 | -87.5% | 0.01% | -86.5% |
| Q2 2021 | $29,637,000 | +27.7% | 652,658 | +17.2% | 0.04% | +23.3% |
| Q1 2021 | $23,210,000 | +139.8% | 556,726 | +145.7% | 0.03% | +328.6% |
| Q4 2020 | $9,678,000 | +162.5% | 226,594 | +58.6% | 0.01% | +16.7% |
| Q3 2020 | $3,687,000 | +143.5% | 142,849 | +84.9% | 0.01% | +100.0% |
| Q1 2018 | $1,514,000 | -23.5% | 77,268 | -20.9% | 0.00% | 0.0% |
| Q4 2017 | $1,980,000 | – | 97,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |